X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
94
PharmaCompass offers a list of Dexlansoprazole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dexlansoprazole manufacturer or Dexlansoprazole supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dexlansoprazole manufacturer or Dexlansoprazole supplier.
PharmaCompass also assists you with knowing the Dexlansoprazole API Price utilized in the formulation of products. Dexlansoprazole API Price is not always fixed or binding as the Dexlansoprazole Price is obtained through a variety of data sources. The Dexlansoprazole Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Dexlansoprazole Sesquihydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dexlansoprazole Sesquihydrate, including repackagers and relabelers. The FDA regulates Dexlansoprazole Sesquihydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dexlansoprazole Sesquihydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dexlansoprazole Sesquihydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dexlansoprazole Sesquihydrate supplier is an individual or a company that provides Dexlansoprazole Sesquihydrate active pharmaceutical ingredient (API) or Dexlansoprazole Sesquihydrate finished formulations upon request. The Dexlansoprazole Sesquihydrate suppliers may include Dexlansoprazole Sesquihydrate API manufacturers, exporters, distributors and traders.
click here to find a list of Dexlansoprazole Sesquihydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dexlansoprazole Sesquihydrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Dexlansoprazole Sesquihydrate active pharmaceutical ingredient (API) in detail. Different forms of Dexlansoprazole Sesquihydrate DMFs exist exist since differing nations have different regulations, such as Dexlansoprazole Sesquihydrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Dexlansoprazole Sesquihydrate DMF submitted to regulatory agencies in the US is known as a USDMF. Dexlansoprazole Sesquihydrate USDMF includes data on Dexlansoprazole Sesquihydrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Dexlansoprazole Sesquihydrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Dexlansoprazole Sesquihydrate suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Dexlansoprazole Sesquihydrate Drug Master File in Korea (Dexlansoprazole Sesquihydrate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Dexlansoprazole Sesquihydrate. The MFDS reviews the Dexlansoprazole Sesquihydrate KDMF as part of the drug registration process and uses the information provided in the Dexlansoprazole Sesquihydrate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Dexlansoprazole Sesquihydrate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Dexlansoprazole Sesquihydrate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Dexlansoprazole Sesquihydrate suppliers with KDMF on PharmaCompass.
A Dexlansoprazole Sesquihydrate written confirmation (Dexlansoprazole Sesquihydrate WC) is an official document issued by a regulatory agency to a Dexlansoprazole Sesquihydrate manufacturer, verifying that the manufacturing facility of a Dexlansoprazole Sesquihydrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Dexlansoprazole Sesquihydrate APIs or Dexlansoprazole Sesquihydrate finished pharmaceutical products to another nation, regulatory agencies frequently require a Dexlansoprazole Sesquihydrate WC (written confirmation) as part of the regulatory process.
click here to find a list of Dexlansoprazole Sesquihydrate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dexlansoprazole Sesquihydrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dexlansoprazole Sesquihydrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dexlansoprazole Sesquihydrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dexlansoprazole Sesquihydrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dexlansoprazole Sesquihydrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dexlansoprazole Sesquihydrate suppliers with NDC on PharmaCompass.
Dexlansoprazole Sesquihydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dexlansoprazole Sesquihydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dexlansoprazole Sesquihydrate GMP manufacturer or Dexlansoprazole Sesquihydrate GMP API supplier for your needs.
A Dexlansoprazole Sesquihydrate CoA (Certificate of Analysis) is a formal document that attests to Dexlansoprazole Sesquihydrate's compliance with Dexlansoprazole Sesquihydrate specifications and serves as a tool for batch-level quality control.
Dexlansoprazole Sesquihydrate CoA mostly includes findings from lab analyses of a specific batch. For each Dexlansoprazole Sesquihydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dexlansoprazole Sesquihydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Dexlansoprazole Sesquihydrate EP), Dexlansoprazole Sesquihydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dexlansoprazole Sesquihydrate USP).
Market Place
